Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vaginal microenvironment is a dynamic and complex biological system consisting of the vaginal microbiota, host mucosal epithelium, and local immune components [1]. In healthy individuals of reproductive age, this environment is typically dominated by Lactobacillus species, which ferment glycogen-derived products into lactic acid to maintain a low vaginal pH (typically <4.5) [2]. This acidity, along with the production of antimicrobial compounds like hydrogen peroxide and bacteriocins, serves as a primary defense mechanism against the colonization of pathogenic organisms [3]. Disruptions to this balance, often referred to as dysbiosis, can lead to conditions such as bacterial vaginosis and increase the risk of acquiring sexually transmitted infections, including HIV [1,4]. Therapeutic strategies targeting this environment focus on eradicating pathogens with antibiotics or antifungals, as well as restoring the protective flora through the use of probiotics and pH-modulating agents [2,3].
Restoration of commensal microbial populations, acidification of the vaginal lumen, and direct antimicrobial activity against pathogenic species.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal microenvironment (VME).